新興
BiPAP A40 EFL Ventilator The first and only purpose-built COPD NIV therapy proven to screen, detect and abolish EFL

BiPAP A40 EFL Ventilator

The first and only purpose-built COPD NIV therapy proven to screen, detect and abolish EFL

尋找類似產品

While the majority of COPD patients have EFL, care teams have never had a COPD NIV ventilation therapy that dynamically and automatically targets EFL. BiPAP A40 EFL is the first and only NIV therapy precision-crafted to abolish EFL in hypercapnic COPD patients. It screens, detects and auto-optimizes pressure – to treat comfortably and redefine what is possible in managing COPD.

技術指標

Prescription guidelines
Prescription guidelines
Pressure (min to max)
  • 4 to 40 cmH2O
BiPAP A40 EFL Modes
  • C, S, S/T, PC (noninvasive)
Ventilation Features
  • AVAPS, Automated Airway Management, ExpiraFlow
Trigger Type
  • Auto-Trak, Sensitive Auto-Trak, Flow Trigger
Breath Rate
  • 0 to 40 BPM (S/T and PC mode), 4 to 40 BPM (T mode)
Inspiratory Time
  • 0.5 to 3 seconds
Low Flow O2
  • 15 L/min at a maximum pressure of 10 psi
Settable Alarms
  • Circuit Disconnect, Apnea, Low Vt (AVAPS), Low Minute Ventilation, High Respiratory Rate, Low SPO2
Humidification
  • Integrated SystemOne: Heated or Heated Tube
Dimensions
  • 22.23 cm W x 18.42 cm L x 10.80 cm H, (8.75” W x 7.25” L x 4.25” H)
Device specifications
Device specifications
Weight
  • Approximately 2 kg (4.4 lbs)
AC Voltage Source
  • 100 to 240 VAC, 50/60 Hz, 1.2 A
DC Power Source
  • 24 VDC, 4.2 A (Power Supply); 12 VDC, 5.0 A (External Battery)
Sound
  • Less than 30 dBA at 10 cmH2O
For a complete list of specifications
  • Please contact your local Representative or consult the user manual
  • 1. Dellaca, R. L., Santus, P., Aliverti, A., Stevenson, N., Centanni, S., Macklem, P. T. & Calverley, P. M. A. (2004). Detection of expiratory flow limitation in COPD using the forced oscillation technique. European Respiratory Journal, 23(2), 232-240.
  • 2. Aarli, B. B., Calverley, P. M., Jensen, R. L., Dellacà, R., Eagan, T. M., Bakke, P. S., & Hardie, J. A. (2017). The association of tidal EFL with exercise performance, exacerbations, and death in COPD. International journal of chronic obstructive pulmonary disease, 12, 2179 † COPD patients with a DeltaXrs ≥ upper normal limit (ULN)
  • 3. ES Suh1, P. P. (2014). Abolition of expiratory flow limitation in severe COPD using auto-titrating CPAP based on the measurement of within-breath airway reactance determined by the forced oscillation technique. †† Context: Stable and Ventilated Hypercapnic COPD patients
  • 4. Key ventilation parameters, alarm data, device performance and patient usag